Jonathan Beadle

Jonathan Beadle is a Senior Scientist at AstraZeneca, where they contribute to advanced research in the field of chemistry. They previously worked as a Medicinal Chemist at Redx Oncology from 2012 to 2014 and held a Postdoctoral Fellowship at the University of Alberta from 2018 to 2020. Jonathan completed their PhD at the University of Warwick, where they studied Oxetane-Based Peptidomimetics, following their Master's degree at The University of Manchester, focusing on Synthetic Peptide Analogues.